Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CureDRPLA Global Patient Registry for Individuals With Dentatorubral-pallidoluysian Atrophy (DRPLA)

NCT05489393 is registered in ClinicalTrials.gov with CureDRPLA as lead sponsor.

NCT NCT05489393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05489393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CureDRPLA Global Patient Registry for Individuals With Dentatorubral-pallidoluysian Atrophy (DRPLA)
Lead sponsor
CureDRPLA
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2021
Completion date
November 1, 2031
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

drpla